A role for P2X7in microglial proliferation
- 8 August 2006
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 99 (3) , 745-758
- https://doi.org/10.1111/j.1471-4159.2006.04101.x
Abstract
Microglia, glial cells with an immunocompetent role in the CNS, react to stimuli from the surrounding environment with alterations of their phenotypic response. Amongst other activating signals, the endotoxin lipopolysaccharide (LPS) is widely used as a tool to mimic bacterial infection in the CNS. LPS‐activated microglia undergo dramatic changes in cell morphology/activity; in particular, they stop proliferating and differentiate from resting to effector cells. Activated microglia also show modifications of purinoreceptor signalling with a significant decrease in P2X7expression. In this study, we demonstrate that the down‐regulation of the P2X7receptor in activated microglia may play an important role in the antiproliferative effect of LPS. Indeed, chronic blockade of the P2X7receptor by antagonists (oxidized ATP, KN62 and Brilliant Blue G), or treatment with the ATP‐hydrolase apyrase, severely decreases microglial proliferation, down‐regulation of P2X7receptor expression by small RNA interference (siRNA) decreases cell proliferation, and the proliferation of P2X7‐deficient N9 clones and primary microglia, in which P2X7expression is down‐regulated by siRNA, is unaffected by either LPS or P2X7antagonists. Furthermore, flow cytometric analysis indicates that exposure to oxidized ATP or treatment with LPS reversibly decreases cell cycle progression, without increasing the percentage of apoptotic cells. Overall, our data show that the P2X7receptor plays an important role in controlling microglial proliferation by supporting cell cycle progression.Keywords
This publication has 56 references indexed in Scilit:
- Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microgliaBrain Research Reviews, 2005
- Identification and characterization of splice variants of the human P2X7 ATP channelBiochemical and Biophysical Research Communications, 2005
- The tyrosine kinase inhibitor AG126 restores receptor signaling and blocks release functions in activated microglia (brain macrophages) by preventing a chronic rise in the intracellular calcium levelJournal of Neurochemistry, 2004
- A Key Role for Caspase-2 and Caspase-3 in the Apoptosis Induced by 2-Chloro-2′-deoxy-adenosine (Cladribine) and 2-Chloro-adenosine in Human Astrocytoma CellsMolecular Pharmacology, 2003
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA)The Journal of cell biology, 1997
- Coexistence of purino‐ and pyrimidinoceptors on activated rat microglial cellsBritish Journal of Pharmacology, 1997
- The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )Science, 1996
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995
- Reorganization of microfilaments in macrophages after LPS stimulationExperimental Cell Research, 1991